期刊文献+

足叶苦素抑制胰岛素样生长因子I受体表达对肝癌细胞增殖与运动的影响 被引量:6

Effects of inhibited IGF-IR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines
原文传递
导出
摘要 目的观察足叶苦素(PPP)抑制胰岛素样生长因子I受体(IGF-IR)后对肝癌细胞增殖和运动的影响。方法体外培养肝细胞L02和肝癌细胞(Bel-7404、Bei-7402、HepG2和Huh_7),以Westemblot分析IGF-IR表达,以磺酰罗丹明B法分析细胞活性;在PPP抑制IGF-IR后,以流式细胞术分析细胞周期,以ArmexinV-FITC法分析细胞凋亡;在z-VAD-FMK抑制caspases后,以均质发光法检测caspase-3/7活性;划痕试验分析细胞运动能力。对数据进行析因设计方差分析,采用t检验或one-wayANOVA法进行组间比较。结果肝细胞L02中几乎检测不到IGF-IR,各肝癌细胞中IGF-IR呈不同程度表达。PPP抑制肝癌细胞增殖呈时间和剂量依赖性,经1.0μmol/LPPP处理HepG2细胞24h,G1、S期和G2/M期细胞比例分别为2.1%±0.4%、11.0%±0.7%和87.1%±0.6%,且划痕不愈合Icaspase-3/7活陛显著增加(t=11.83,P〈0.01);HepG2细胞凋亡率为16.4%±0.4%,明显高于对照组的5.8%±0.2%(f=14.05,P〈0.01);z-VAD-FMK抑制casgases表达,HepG2细胞凋亡率为11.3%±0.7%,明显高于对照组的5.8%±0.2%(f=11.83,P〈0.01)。结论IGF-IR表达与肝癌细胞增殖、运动和凋亡相关,可能是肝癌分子靶向治疗的有效靶点。 Objective To investigate the therapeutic value of inhibiting the expression of insulin- like growth factor-I receptor (IGF-IR) using picropodophyllin (PPP) by studying the effects on proliferative and metastatic potentials of human hepatocellular carcinoma (HCC) using an in vitro cultured cell system. Methods IGF-IR expression in human HCC cell lines (Bel-7404, Bel-7402, HepG2, and Huh-7) and human hepatocytes (L02) was assessed'at baseline (pre-treatment) and after PPP treatment by western blotting. Changes in cell cycle were analyzed by flow cytometry and in cell viability by sulforhodamine B staining. Early apoptosis was detecte0/by annexin-V/FITC and propidium iodide double-staining assay. Caspase-3/7 / activity was suppressed by/z-VAD-FMK and analyzed by homogeneous luminescence assay. Effects on cell motility were tested by v/ound-scratch test. Between-group differences were assessed by t-test or one-way analysis of variance. Results IGF-IR was markedly up-regulated in all HCC cell lines (vs. non-hepatoma hepatocytes). HCC cells with PPP-inhibited IGF-IR showed time-dependent decreases in cell motility and After treatment with PPP for 24 hours, the proportion of HCC cells in G1 phase was 2.1% -4- 0.4%, viability. in S phase was 11.0% - 0.7%, and 'in G2/M phase was 87.1% - 0.6%, and no healing was observed in the wound-scratch assay. The PPP treatment induced cell apoptosis, as evidenced by enhanced caspase-3/7activity; the proportion of annexin-V+/PI cells was significantly higher in the HepG2 cells than in the non- hepatoma hepatocytes (16.4%± 0.4% vs. 5.8% ±0.2%, t = 14.05,P 〈 0.01). After z-VAD-FMK treatment, the apoptosis rate was significantly higher in the HepG2 cells than in the non-hepatoma hepatocytes ( 11.3% ±0.7% vs. 5.8%± 0.2%, t = 11.83, P 〈 0.01). Conclusion IGF-IR is associated with proliferation, cell motility, and apoptosis of HCC ceils, and may be a promising molecular target for HCC.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2013年第5期376-380,共5页 Chinese Journal of Hepatology
基金 国家国际科技合作专项(2013DFA32150)}江苏省临床医学科技专项(BL2012053) 江苏省研究生科技创新项目(CXZZ110645) 南通市科技项目(HS2012039)
关键词 肝细胞 细胞凋亡 受体 胰岛素样生长因子I 靶向治疗 Carcinoma, hepatocellular Apoptosis Receptor, insulin-like growth factor-I Targeted therapy
  • 相关文献

参考文献8

  • 1Yang ill, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol, 2010, 7: 448-458.
  • 2Sia D, Villanueva A. Signaling pathways in hepatocellular carcinoma. Oncology, 2011, 81 Suppl 1: 18-23.
  • 3Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer, 2012,12: 159-169.
  • 4Jiang J, Eliaz I, Sliva D. Suppression of growth and invasive behavior of human prostate cancer cells by ProstaCaid?: mechanism ofactivity.lnt J Oncol, 2011, 38: 1675-1682.
  • 5Vasilcanu R, Vasilcanu D, Rosengren L, et al. Picropodophyllin induces downregulation of the insulin-like growth factor I receptor: potential mechanistic involvement of Mdm2 and beta-arrestin I. Oncogene, 2008, 27: 1629-1638.
  • 6Ekman S, Fredin JE, Harmenberg J, et al. Clinical Phase I study with an insulin-like growth factor-I receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma. Acta Oncol, 2011,50:441-447.
  • 7Vishwamitra D, Shi P, Wilson D, et al. Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma. Haematologica, 2011, 96: 871-880.
  • 8Attias-Geva Z, Bentov I, Ludwig DL, et al. Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A 12) inhibits IGF-I action in endometrial cancer cells. Eur J Cancer, 2011,47: 1717-1726.

同被引文献33

  • 1陆园园,姚登福,吴信华,黄华,邱历伟,吴玮.肝癌及癌旁组织IGF-Ⅰ受体表达及临床病理学特征[J].南通大学学报(医学版),2008,28(3):169-171. 被引量:11
  • 2Xiao-Di Yan,Min Yao,Li Wang,Hai-Jian Zhang,Mei-Juan Yan,Xing Gu,Yun Shi,Jie Chen,Zhi-Zhen Dong,Deng-Fu Yao.Overexpression of insulin-like growth factor-Ⅰ receptor as a pertinent biomarker for hepatocytes malignant transformation[J].World Journal of Gastroenterology,2013,19(36):6084-6092. 被引量:18
  • 3GILLET JP, ANDERSEN JB, MADIGAN JP, et al. A gene ex- pression signature associated with overall survival in patients with hepatocellular carcinoma suggests a new treatment strate- gy[J]. Mol Pharmacol, 2016, 89(2) : 263 -272.
  • 4PENG H, LI QL, HOU SH, et al. Association of genetic poly- morphisms in CD8 + T cell inhibitory genes and susceptibility to and progression of chronic HBV infection [ J ]. Infect Genet Evol, 2015, 36:467 -474.
  • 5THOLEY DM, AHN J. Impact of hepatitis C virus infection on hepatocellular carcinoma [ J ]. Gastroenterol Clin North Am, 2015, 44(4) ~ 761 -773.
  • 6CHEN S, WANG Y, RUAN W, et al. Reversing multidrug re- sistance in hepatocetlular carcinoma ceils by inhibiting extra- cellular signal - regulated kinase/mitogen - activated protein kinase signaling pathway activity[J]. Oncol Lett, 2014, 8 (5) ; 2333 -2339.
  • 7HO CT, SHANG HS, CHANG JB, et al. Folate deficiency - triggered redox pathways confer drug resistance in hepato- cellular carcinoma[J]. Oncotarget, 2015, 6(28): 26104- 26118.
  • 8ZHENG W, SAI W, YAO M, et al. Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2/ADM cells [ J ]. Tumour Biol, 2015, 36(5) : 3995 -4003.
  • 9DONG ZZ, YAO M, WANG L, et al. Abnormal expression of insulin -like growth factor- I receptor in hepatoma tissues and its inhibition promoting apoptosis of tumor cells [ J ]. Tumor Biol0 2013, 34(6) : 3397 -3405.
  • 10CHANG TS, WU YC, CHI CC, et al. Activation of IL6/IGF I R confers poor prognosis of HBV - related hepatocellular car- cinoma through induction of OCT4/NANOG expression[J]. Clin Cancer Res, 2015, 21 (1) : 201 -210.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部